NDC 49702-255

Tivicay PD

Dolutegravir Sodium

Tivicay PD is a Oral Tablet, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Dolutegravir Sodium.

Product ID49702-255_2938dd60-8dbb-45c2-aa80-ae568c363589
NDC49702-255
Product TypeHuman Prescription Drug
Proprietary NameTivicay PD
Generic NameDolutegravir Sodium
Dosage FormTablet, For Suspension
Route of AdministrationORAL
Marketing Start Date2020-06-12
Marketing CategoryNDA / NDA
Application NumberNDA213983
Labeler NameViiV Healthcare Company
Substance NameDOLUTEGRAVIR SODIUM
Active Ingredient Strength5 mg/1
Pharm ClassesHIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 49702-255-37

1 BOTTLE in 1 CARTON (49702-255-37) > 60 TABLET, FOR SUSPENSION in 1 BOTTLE
Marketing Start Date2020-06-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tivicay PD" or generic name "Dolutegravir Sodium"

NDCBrand NameGeneric Name
49702-255Tivicay PDdolutegravir sodium
49702-226Tivicaydolutegravir sodium
49702-227Tivicaydolutegravir sodium
49702-228Tivicaydolutegravir sodium
50090-1355Tivicaydolutegravir sodium
53808-1130Tivicaydolutegravir sodium
67296-1818Tivicaydolutegravir sodium
70518-1487Tivicaydolutegravir sodium

Trademark Results [Tivicay PD]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TIVICAY PD
TIVICAY PD
90022555 not registered Live/Pending
ViiV Healthcare Company
2020-06-26
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.